← Browse by Condition
Medical Condition

locally advanced or metastatic egfrm non small cell lung cancer nsclc

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT07058519 Phase 2
Recruiting

A Study of Osimertinib-based Adaptive Treatment Guided by ctDNA EGFRm+ Monitoring in NSCLC

Enrollment
250 pts
Location
China
Sponsor
Shanghai Chest Hospital
View Trial →